Literature DB >> 25412335

Masturbation frequency and sexual function domains are associated with serum reproductive hormone levels across the menopausal transition.

John F Randolph1, Huiyong Zheng, Nancy E Avis, Gail A Greendale, Siobán D Harlow.   

Abstract

OBJECTIVE: To determine whether reproductive hormones are related to sexual function during the menopausal transition.
DESIGN: The Study of Women's Health Across the Nation (SWAN) is a multiethnic cohort study of the menopausal transition located at seven US sites. At baseline, the 3302 community-based participants, aged 42-52, had an intact uterus and at least one ovary and were not using exogenous hormones. Participants self-identified as White, Black, Hispanic, Chinese, or Japanese. At baseline and at each of the 10 follow-up visits, sexual function was assessed by self-administered questionnaires, and blood was drawn to assay serum levels of T, estradiol, FSH, SHBG, and dehydroepiandrosterone sulfate. MAIN OUTCOME MEASURES: Self-reported frequency of masturbation, sexual desire, sexual arousal, orgasm, and pain during intercourse.
RESULTS: Masturbation, sexual desire, and arousal were positively associated with T. Masturbation, arousal, and orgasm were negatively associated with FSH. Associations were modest. Estradiol was not related to any measured sexual function domain. Pain with intercourse was not associated with any hormone.
CONCLUSIONS: Reproductive hormones were associated with sexual function in midlife women. T was positively associated, supporting the role of androgens in female sexual function. FSH was negatively associated, supporting the role of menopausal status in female sexual function. The modest associations in this large study suggest that the relationships are subtle and may be of limited clinical significance.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25412335      PMCID: PMC4283018          DOI: 10.1210/jc.2014-1725

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  27 in total

1.  Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men.

Authors:  A W van den Beld; F H de Jong; D E Grobbee; H A Pols; S W Lamberts
Journal:  J Clin Endocrinol Metab       Date:  2000-09       Impact factor: 5.958

Review 2.  Hormonal influences in female sexual response.

Authors:  F J Kane; M A Lipton; J A Ewing
Journal:  Arch Gen Psychiatry       Date:  1969-02

3.  Hormones, mood, sexuality, and the menopausal transition.

Authors:  Lorraine Dennerstein; John Randolph; John Taffe; Emma Dudley; Henry Burger
Journal:  Fertil Steril       Date:  2002-04       Impact factor: 7.329

4.  Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women.

Authors:  H G Burger; E C Dudley; J L Hopper; N Groome; J R Guthrie; A Green; L Dennerstein
Journal:  J Clin Endocrinol Metab       Date:  1999-11       Impact factor: 5.958

5.  Change in follicle-stimulating hormone and estradiol across the menopausal transition: effect of age at the final menstrual period.

Authors:  John F Randolph; Huiyong Zheng; MaryFran R Sowers; Carolyn Crandall; Sybil Crawford; Ellen B Gold; Marike Vuga
Journal:  J Clin Endocrinol Metab       Date:  2010-12-15       Impact factor: 5.958

6.  Are changes in sexual functioning during midlife due to aging or menopause?

Authors:  L Dennerstein; E Dudley; H Burger
Journal:  Fertil Steril       Date:  2001-09       Impact factor: 7.329

7.  A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition.

Authors:  H G Burger; E C Dudley; J Cui; L Dennerstein; J L Hopper
Journal:  J Clin Endocrinol Metab       Date:  2000-08       Impact factor: 5.958

8.  Change in estradiol and follicle-stimulating hormone across the early menopausal transition: effects of ethnicity and age.

Authors:  John F Randolph; MaryFran Sowers; Irina V Bondarenko; Siobán D Harlow; Judith L Luborsky; Roderick J Little
Journal:  J Clin Endocrinol Metab       Date:  2004-04       Impact factor: 5.958

9.  Sexual functioning and practices in a multi-ethnic study of midlife women: baseline results from SWAN.

Authors:  Virginia S Cain; Catherine B Johannes; Nancy E Avis; Beth Mohr; Miriam Schocken; Joan Skurnick; Marcia Ory
Journal:  J Sex Res       Date:  2003-08

10.  Predictors of decreased libido in women during the late reproductive years.

Authors:  Clarisa R Gracia; Mary D Sammel; Ellen W Freeman; Li Liu; Lori Hollander; Deborah B Nelson
Journal:  Menopause       Date:  2004 Mar-Apr       Impact factor: 3.310

View more
  14 in total

1.  Sexual dysfunction in 2015: Recovering sex drive in women - progress and opportunities.

Authors:  Rossella E Nappi; Francesca Albani
Journal:  Nat Rev Urol       Date:  2016-01-12       Impact factor: 14.432

Review 2.  Symptoms of menopause - global prevalence, physiology and implications.

Authors:  Patrizia Monteleone; Giulia Mascagni; Andrea Giannini; Andrea R Genazzani; Tommaso Simoncini
Journal:  Nat Rev Endocrinol       Date:  2018-02-02       Impact factor: 43.330

3.  Dehydroepiandrosterone and cortisol as markers of HPA axis dysregulation in women with low sexual desire.

Authors:  Rosemary Basson; Julia I O'Loughlin; Joanne Weinberg; Allan H Young; Tamara Bodnar; Lori A Brotto
Journal:  Psychoneuroendocrinology       Date:  2019-03-08       Impact factor: 4.905

4.  Change in sexual functioning over the menopausal transition: results from the Study of Women's Health Across the Nation.

Authors:  Nancy E Avis; Alicia Colvin; Arun S Karlamangla; Sybil Crawford; Rachel Hess; L Elaine Waetjen; Maria Brooks; Ping G Tepper; Gail A Greendale
Journal:  Menopause       Date:  2017-04       Impact factor: 2.953

5.  Patterns of Sexual Activity and the Development of Sexual Pain Across the Menopausal Transition.

Authors:  L Elaine Waetjen; Wesley O Johnson; Guibo Xing; Rachel Hess; Nancy E Avis; Barbara D Reed; Sheila A Dugan; Genevieve Neal-Perry; Ellen B Gold
Journal:  Obstet Gynecol       Date:  2022-05-02       Impact factor: 7.623

6.  Are serum estrogen concentrations associated with menopausal symptom bother among postmenopausal women? Baseline results from two MsFLASH clinical trials.

Authors:  Carolyn J Crandall; Joseph C Larson; Kristine E Ensrud; Andrea Z LaCroix; Katherine A Guthrie; Susan D Reed; Shalender Bhasin; Susan Diem
Journal:  Maturitas       Date:  2022-04-25       Impact factor: 5.110

7.  Effect of radiotherapy for rectal cancer on ovarian androgen production.

Authors:  J Segelman; C Buchli; A Svanström Röjvall; P Matthiessen; S Arver; M Bottai; M Ahlberg; R Jasuja; A Flöter-Rådestad; A Martling
Journal:  Br J Surg       Date:  2018-09-12       Impact factor: 6.939

8.  Androgen-dependent immune modulation in parasitic infection.

Authors:  Julie Sellau; Marie Groneberg; Hannelore Lotter
Journal:  Semin Immunopathol       Date:  2018-10-23       Impact factor: 9.623

9.  Sexual activity and vaginal symptoms in the postintervention phase of the Women's Health Initiative Hormone Therapy Trials.

Authors:  Margery Gass; Joseph Larson; Barbara Cochrane; JoAnn E Manson; Dorothy Lane; Vanessa Barnabei; Judith Ockene; Marcia L Stefanick; Charles Mouton
Journal:  Menopause       Date:  2018-03       Impact factor: 2.953

Review 10.  The menopause transition and women's health at midlife: a progress report from the Study of Women's Health Across the Nation (SWAN).

Authors:  Samar R El Khoudary; Gail Greendale; Sybil L Crawford; Nancy E Avis; Maria M Brooks; Rebecca C Thurston; Carrie Karvonen-Gutierrez; L Elaine Waetjen; Karen Matthews
Journal:  Menopause       Date:  2019-10       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.